|
| |
NexBio IncorporatedIn recent years the world has witnessed the outbreak of SARS, the worldwide spread of avian influenza viruses, and the escalating outbreaks of avian
influenza viruses in humans. The present unavailability of a vaccine against
avian influenza infection in humans is of grave concern. Health authorities
worldwide fear an imminent and inevitable influenza pandemic in addition to
the more routine but still serious threats posed by annual influenza and other
respiratory pathogens. The inadequacy of current prophylactic and
therapeutic modalities has become all too clear. In response, NexBio, Inc. is
developing broad-spectrum therapeutic and prophylactic agents to protect the
public from all annual and pandemic variations of influenza, as well as from
other life-threatening respiratory viral infections.
| Contact Details: |
| 6330 Nancy Ridge Dr., Suite 105 |
| San Diego |
| California |
| 92121 |
| United States of America |
| Tel: | 858-452-2631 |
| Fax: | |
| Email: | |
| WWW: | www.nexbio.com/
|
|
Loading...
|
Recent Publications by NexBio Incorporated: |  |
Inhibition of neuraminidase inhibitor-resistant influenza virus by DAS181, a novel sialidase fusion protein.
Antiviral drug resistance for influenza therapies remains a concern due to... | 7th November, 2009
| NexBio Inc, San Diego, CA, USA.
| PLoS One. 2009 Nov 6;4(11):e7838.
DOI Direct Link |
Novel pandemic influenza A(H1N1) viruses are potently inhibited by DAS181, a sialidase fusion protein.
BACKGROUND: The recent emergence of a novel pandemic influenza A(H1N1)... | 7th November, 2009
| NexBio Inc, San Diego, CA, USA.
| PLoS One. 2009 Nov 6;4(11):e7788.
DOI Direct Link |
Sialidase fusion protein as a novel broad-spectrum inhibitor of influenza virus infection.
Influenza is a highly infectious disease characterized by recurrent annual... | 10th June, 2006
| NexBio, Inc., 6330 Nancy Ridge Dr., Suite 105, San Diego, CA 92121, USA.
| Antimicrob Agents Chemother. 2006 Apr;50(4):1470-9.
DOI Direct Link |
Viral receptor blockage by multivalent recombinant antibody fusion proteins: inhibiting human rhinovirus (HRV) infection with CFY196.
Viral receptor blockage by monoclonal antibodies (mAbs) is a common... | 24th April, 2004
| NexBio, Inc., 6650 Lusk Boulevard, Suite B102, San Diego, CA 92121, USA.
| J Antimicrob Chemother. 2004 Jan;53(1):23-5. Epub 2003 Dec 4.
DOI Direct Link |
 Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.
This page has been viewed 475 times since April 2007, the link to the organisation's website has been followed 76 times Recent Search Terms used to find this page: nexbio multivalent | NexBio | nexbio | nexbio | . Search for more companies in San Diego Search for more companies in California This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.BioPortfolio search results for NexBio Incorporated |
